Petros Pharmaceuticals
Stock Forecast, Prediction & Price Target
Petros Pharmaceuticals Financial Estimates
Petros Pharmaceuticals Revenue Estimates
Petros Pharmaceuticals EBITDA Estimates
Petros Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $7.81M N/A | $5.99M -23.28% | $5.82M -2.83% | Avg: $5.47M Low: $5.47M High: $5.47M avg. -5.96% | Avg: $11.02M Low: $11.02M High: $11.02M avg. 101.38% | Avg: $20.62M Low: $20.62M High: $20.62M avg. 87.05% | Avg: $27.78M Low: $27.78M High: $27.78M avg. 34.71% |
Net Income
% change YoY
| $-9.35M N/A | $-27.03M -189.00% | $-8.16M 69.80% | Avg: $-7.09M Low: $-7.09M High: $-7.09M avg. 13.09% | Avg: $-5.41M Low: $-5.41M High: $-5.41M avg. 23.61% | Avg: $-1.63M Low: $-1.63M High: $-1.63M avg. 69.87% | Avg: $739.84K Low: $739.84K High: $739.84K avg. 145.33% |
EBITDA
% change YoY
| $-11.17M N/A | $-6.84M 38.74% | $-4.21M 38.44% | Avg: $-5.19M Low: $-5.19M High: $-5.19M avg. -23.31% | Avg: $-10.45M Low: $-10.45M High: $-10.45M avg. -101.38% | Avg: $-19.56M Low: $-19.56M High: $-19.56M avg. -87.05% | Avg: $-26.35M Low: $-26.35M High: $-26.35M avg. -34.71% |
EPS
% change YoY
| -$8.59 N/A | -$13.06 -52.03% | -$6.35 51.37% | Avg: -$3.26 Low: -$3.26 High: -$3.26 avg. 48.66% | Avg: -$2.49 Low: -$2.49 High: -$2.49 avg. 23.61% | Avg: -$0.75 Low: -$0.75 High: -$0.75 avg. 69.87% | Avg: $0.34 Low: $0.34 High: $0.34 avg. 145.33% |
Operating Expenses
% change YoY
| $24.25M N/A | $19.54M -19.42% | $17.80M -8.89% | Avg: $9.34M Low: $9.34M High: $9.34M avg. -47.54% | Avg: $18.81M Low: $18.81M High: $18.81M avg. 101.38% | Avg: $35.18M Low: $35.18M High: $35.18M avg. 87.05% | Avg: $47.40M Low: $47.40M High: $47.40M avg. 34.71% |
FAQ
What is Petros Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 62.98% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -7.09M, average is -7.09M and high is -7.09M.
What is Petros Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 54.29% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $5.47M, average is $5.47M and high is $5.47M.
What is Petros Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 71.87% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$3.26, average is -$3.26 and high is $-3.26.